|Bid||17.00 x N/A|
|Ask||18.50 x N/A|
|Day's range||17.00 - 18.50|
|52-week range||4.65 - 51.00|
|Beta (5Y monthly)||0.91|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
LONDON, July 26, 2021--Kanabo Group Plc (LSE:KNB) ("Kanabo" or the "Company"), the first medical cannabis company to IPO on London Stock Exchange, has signed a Letter of Intent to acquire Materia, a leading processor and distributor of medical cannabis and CBD wellness products across Europe.
LONDON, July 14, 2021--Kanabo, the first medicinal cannabis company to IPO on London Stock Exchange, will be delivering its medicinal cannabis formula to the UK this month, as scheduled. The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod.
LONDON, June 29, 2021--Medical cannabis R&D company, Kanabo Group Plc, today announced that it has appointed Dr Dan Poulter MP as a Non-Executive Director to the board. As both a former UK Government health minister, and as the chairperson of the All-Party Parliamentary Group for Global Health, Dr Poulter has a detailed knowledge of the drugs and medicines regulatory framework in the UK. His blend of medical, governmental, and healthcare policy experience makes him well positioned to support Kan